Subsidy Tracker Parent Company Summary
Parent Company Name:
Pfizer
Ownership Structure:
publicly traded (ticker symbol PFE)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
|---|---|---|
| State/Local | $321,218,841 | 189 |
| Federal (grants and allocated tax credits) | $54,408,698 | 29 |
| TOTAL | $375,627,539 | 218 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $220,000,000 | 1 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $220,000,000 | 1 |
Time Period for State and Local Awards:
Earliest year of data: 1992. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.
Time Period for Federal Awards:
FY2000 to the present
Notes:
Dollar totals do not include awards for which no subsidy value is disclosed.
Associated Names:
ALPHARMA SPECIALTY PHARMA; AMERICAN HOME PROD; ANACOR PHARMACEUTICALS; BIOREXIS; DORAL / PFIZER; EMBREX; FOLDRX PHARMACEUTICALS; GD SEARLE; HOSPIRA; ICAGEN; INNOPHARMA; KING PHARMACEUTICALS LLC; KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT; PARKE DAVIS; PARKEDALE PHARMACEUTICALS; PFIZER; PFIZER HOLDING AMERICAS; PHARMACIA; SERENEX; UPJOHN; WARNER LAMBERT; WYETH
Links:
For a summary of this company's regulatory violations see its Violation Tracker summary page here.
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
For a summary of this company's federal contracts, see its page on Fedspending.
For an overview of political contributions associated with this company, see its Follow the Money page.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
|---|---|---|
| Michigan | $85,200,000 | 2 |
| Connecticut | $60,000,000 | 1 |
| North Carolina | $49,205,269 | 74 |
| New York | $44,472,079 | 26 |
| New Jersey | $38,807,831 | 5 |
| All other | $43,533,662 | 81 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
| Company | Location | Subsidy Source | Year | Subsidy Value |
Loan/Bailout Value |
Type of Subsidy |
|---|---|---|---|---|---|---|
| Pfizer, Inc. | Missouri | local | 2017 | $220,000,000 | loan or bond financing | |
| Pfizer | Michigan | multiple | 2001 | $84,200,000 |
MEGADEAL  |
|
| Pfizer | Connecticut | multiple | 1998 | $60,000,000 |
MEGADEAL |
|
| Wyeth Holdings Corporation | North Carolina | state | 2008 | $18,128,934 | tax credit/rebate | |
| Pharmacia & Upjohn Company | New Jersey | state | 1998 | $12,500,000 | grant | |
| Pfizer | New York | local | 2003 | $10,401,000 | tax credit/rebate; property tax abatement | |
| Pfizer Inc. | New Jersey | state | 2010 | $9,182,250 | grant | |
| Pharmacia Corporation, Affiliates and Subsidiaries | New Jersey | state | 2001 | $8,752,000 | grant | |
| King Pharmaceuticals, Inc. | New Jersey | state | 2005 | $8,253,750 | grant | |
| WYETH PHARMACEUTICALS INC | United States | federal | 2003 | $7,271,925 | federal grant | |
| WYETH PHARMACEUTICALS INC | United States | federal | 2005 | $6,364,931 | federal grant | |
| WYETH | United States | federal | 2005 | $5,636,276 | federal grant | |
| Pfizer, Inc. | New York | local | 2007 | $5,510,432 | tax credit/rebate; property tax abatement | |
| Pfizer, Inc. | Pennsylvania | state | 2011 | $5,195,497 | tax credit/rebate | |
| WYETH PHARMACEUTICALS INC | United States | federal | 2005 | $4,934,072 | federal grant | |
| Wyeth Holdings Corporation | North Carolina | state | 2013 | $4,097,786 | tax credit/rebate | |
| Pfizer, Inc. | Pennsylvania | state | 2010 | $4,091,278 | tax credit/rebate | |
| PFIZER INC. | United States | federal | 2014 | $3,823,709 | federal grant | |
| AMERICAN HOME PRODUCTS CORPORATION | United States | federal | 2000 | $3,773,578 | federal grant | |
| Pfizer, Inc. | New York | local | 2006 | $3,750,210 | tax credit/rebate; property tax abatement | |
| AMERICAN HOME PRODUCTS CORPORATION | United States | federal | 2004 | $3,582,393 | federal grant | |
| Wyeth Holdings Corporation | North Carolina | state | 2014 | $3,476,438 | tax credit/rebate | |
| Pfizer, Inc. | New York | local | 2005 | $3,276,473 | tax credit/rebate; property tax abatement | |
| AMERICAN HOME PRODUCTS CORPORATION | United States | federal | 2001 | $3,247,250 | federal grant | |
| PHARMACIA CORPORATION | Missouri | state | 2002 | $3,235,374 | tax credit/rebate | |
| Doral Arrowwood (Pfizer) | New York | local | 2004 | $3,137,110 | tax credit/rebate; property tax abatement | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $3,000,000 | grant | |
| WYETH PHARMACEUTICALS INC | United States | federal | 2002 | $2,968,632 | federal grant | |
| Pfizer, Inc. | New York | state | 2003 | $2,956,000 | enterprise zone | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2008 | $2,872,836 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2009 | $2,868,194 | tax credit/rebate | |
| PFIZER INC. | United States | federal | 2014 | $2,784,665 | federal grant | |
| Pfizer, Inc. | New York | state | 2002 | $2,783,900 | enterprise zone | |
| Pfizer, Inc. | Pennsylvania | state | 2009 | $2,715,300 | tax credit/rebate | |
| Pfizer, Inc. | Tennessee | local | 2017 | $2,582,313 | property tax abatement | |
| Doral Arrowwood (Pfizer) | New York | local | 2006 | $2,022,893 | tax credit/rebate; property tax abatement | |
| PFIZER, INC. | Missouri | state | 2007 | $2,000,000 | training reimbursement | |
| Wyeth Pharmaceuticals | Virginia | state | 2004 | $2,000,000 | grant | |
| Pfizer, Inc. | New York | local | 2004 | $1,919,713 | tax credit/rebate; property tax abatement | |
| AMERICAN HOME PRODUCTS CORPORATION | United States | federal | 2002 | $1,894,602 | federal grant | |
| Hospira, Inc. | North Carolina | state | 2004 | $1,812,000 | grant | |
| Hospira, Inc. | North Carolina | state | 2010 | $1,665,848 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2009 | $1,653,115 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2009 | $1,617,030 | tax credit/rebate | |
| AMERICAN HOME PRODUCTS CORPORATION | United States | federal | 2003 | $1,616,058 | federal grant | |
| EMBREX, INC. | United States | federal | 2005 | $1,403,707 | federal grant | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2007 | $1,385,605 | tax credit/rebate | |
| Pfizer, Inc. | North Carolina | state | 2015 | $1,320,134 | tax credit/rebate | |
| Pfizer Inc. | Pennsylvania | state | 2008 | $1,257,546 | tax credit/rebate | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2006 | $1,250,000 | tax credit/rebate | |
| G.D. SEARLE & COMPANY | Missouri | state | 2002 | $1,126,728 | tax credit/rebate | |
| Pfizer, Inc. | North Carolina | state | 2016 | $1,013,383 | tax credit/rebate | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $1,000,000 | tax credit/rebate | |
| Pfizer, Inc. | Michigan | state | 2019 | $1,000,000 | tax credit/rebate | |
| Pfizer Inc & Subsidiaries | Iowa | state | 2010 | $942,184 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2009 | $932,710 | tax credit/rebate; property tax abatement | |
| Pfizer, Inc. | New York | local | 2008 | $862,541 | tax credit/rebate; property tax abatement | |
| Wyeth | Pennsylvania | state | 2008 | $802,021 | tax credit/rebate | |
| PFIZER INC. | United States | federal | 2014 | $787,834 | federal grant | |
| Pfizer, Inc. | North Carolina | state | 2013 | $755,362 | tax credit/rebate | |
| Pfizer, Inc. | North Carolina | state | 2013 | $755,362 | tax credit/rebate | |
| Doral Arrowwood (Pfizer) | New York | local | 2005 | $701,075 | tax credit/rebate; property tax abatement | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2008 | $668,300 | tax credit/rebate | |
| PFIZER INC. | United States | federal | 2015 | $664,225 | federal grant | |
| Doral/Pfizer | New York | local | 2007 | $662,163 | tax credit/rebate; property tax abatement | |
| Hospira inc | Kansas | state | 2013 | $650,000 | grant | |
| Hospira, Inc. | North Carolina | state | 2015 | $623,585 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2003 | $613,020 | tax credit/rebate; property tax abatement | |
| Pfizer, Inc. | North Carolina | state | 2012 | $607,213 | tax credit/rebate | |
| Pfizer, Inc. | North Carolina | state | 2012 | $607,213 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2014 | $607,052 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2010 | $596,605 | tax credit/rebate; property tax abatement | |
| Hospira, Inc. | North Carolina | state | 2008 | $537,281 | tax credit/rebate | |
| HOSPIRA, INC. | California | state | 2009 | $536,590 | training reimbursement | |
| BIOREXIS PHARMACEUTICAL CORPORATION | United States | federal | 2004 | $523,510 | federal grant | |
| ANACOR PHARMACEUTICALS INC | United States | federal | 2014 | $519,843 | federal grant | |
| ANACOR PHARMACEUTICALS INC | United States | federal | 2014 | $519,575 | federal grant | |
| Doral/Pfizer | New York | local | 2013 | $516,004 | tax credit/rebate; property tax abatement | |
| Pfizer, Inc. | North Carolina | state | 2011 | $501,793 | tax credit/rebate | |
| Wyeth-Ayerst Pharmaceuticals | Pennsylvania | state | $500,000 | grant | ||
| Wyeth Pharmaceuticals, Inc. | Pennsylvania | state | $500,000 | grant | ||
| Wyeth-Lederle (#2) | North Carolina | state | 2004 | $500,000 | grant | |
| Pfizer, Inc. | New York | state | 2005 | $500,000 | enterprise zone | |
| EMBREX | United States | federal | 2005 | $494,265 | federal grant | |
| Hospira, Inc. | North Carolina | state | 2013 | $483,750 | grant | |
| Doral/Pfizer | New York | local | 2008 | $462,392 | tax credit/rebate; property tax abatement | |
| HOSPIRA, INC. | California | state | 2006 | $439,595 | training reimbursement | |
| Pfizer Inc., and Subsidiaries | Maryland | state | 2015 | $427,891 | tax credit/rebate | |
| Hospira, Inc. | North Carolina | state | 2016 | $415,010 | tax credit/rebate | |
| Hospira, Inc. and Subsidiaries | Illinois | state | 2007 | $404,000 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2015 | $402,469 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2016 | $402,469 | tax credit/rebate | |
| Wyeth Holdings Corporation | North Carolina | state | 2010 | $373,801 | tax credit/rebate | |
| Doral/Pfizer | New York | local | 2011 | $360,540 | tax credit/rebate; property tax abatement | |
| Doral/Pfizer | New York | local | 2012 | $357,613 | tax credit/rebate; property tax abatement | |
| FoldRx Pharmaceuticals Inc. | United States | federal | 2009 | $350,000 | federal grant | |
| FoldRx Pharmaceuticals, Inc. | United States | federal | 2008 | $350,000 | federal grant | |
| Hospira, Inc. | North Carolina | state | 2011 | $344,981 | tax credit/rebate | |
| PFIZER, INC. | Missouri | state | 2000 | $315,055 | tax credit/rebate | |
| WYETH HOLDINGS CORPORATION | New York | local | 2009 | $280,900 | tax credit/rebate; property tax abatement | |
| Hospira, Inc. | North Carolina | state | 2016 | $277,903 | tax credit/rebate |
